RETRACTED: Synthesis and Biological Evaluation of Entecavir 4′-Ester Derivatives (Retracted article. See vol. 31, pg. 1078, 2015)

被引：3

作者：

Feng Deri ^{[1
]}

Liu Jiaan ^{[1
]}

Liang Shuang ^{[1
]}

Wang Yanyan ^{[1
]}

Xu Youjun ^{[1
]}

机构：

[1] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang 110016, Peoples R China

来源：

CHEMICAL RESEARCH IN CHINESE UNIVERSITIES | 2014年 / 30卷 / 05期

基金：

中国国家自然科学基金;

关键词：

Entecavir; Anti-HBV activity; Intestinal membrane permeability; HEPATITIS-B-VIRUS; PHARMACOKINETICS; INFECTION; PRODRUG; POTENT; ACID; LAMIVUDINE; TRIAL; DRUG;

D O I：

10.1007/s40242-014-4183-y

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Entecavir can significantly inhibit the replication of HBV-DNA, reduce the HBV-DNA level in blood serum. But suffering from low oral bioavailability, entecavir has low intestinal membrane permeability and poor metabolic stability. In this study, 12 different derivatives of entecavir 4'-ester were regioselectively synthesized and their apical-to-basolateral permeabilities across Caco-2 cells and HBV-DNA inhibitory efficacies were evaluated. Most of the compounds showed high permeabilities across Caco-2 cells compared with entecavir, compounds 5b and 5e also exhibited comparable anti-BBV activities with that of entecavir, especially.

引用

页码：749 / 754

页数：6

共 26 条

[1] Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir
Balimane, PV
Tamai, I
Guo, AL
Nakanishi, T
Kitada, H
Leibach, FH
Tsuji, A
Sinko, PJ
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (02) : 246 - 251
[2] 4-Benzyl- and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones, a new family of potent anti-HIV agents:: Optimization and in vitro evaluation against clinically important HIV mutant strains
Benjahad, A
Courté, K
Guillemont, J
Mabire, D
Coupa, S
Poncelet, A
Csoka, I
Andries, K
Pauwels, R
de Béthune, MP
Monneret, C
Bisagni, E
Nguyen, CH
Grierson, DS
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (22) : 5501 - 5514
[3] Dipeptides as effective prodrugs of the unnatural amino acid (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740), a selective group II metabotropic glutamate receptor agonist
Bueno, AB
Collado, I
de Dios, A
Domínguez, C
Martín, JA
Martín, LM
Martínez-Grau, MA
Montero, C
Pedregal, C
Catlow, J
Coffey, DS
Clay, MP
Dantzig, AH
Lindstrom, T
Monn, JA
Jiang, HY
Schoepp, DD
Stratford, RE
Tabas, LB
Tizzano, JP
Wright, RA
Herin, MF
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) : 5305 - 5320
[4] Entecavir, FTC, L-FMAU, LdT and others
Buti, M
Esteban, R
[J]. JOURNAL OF HEPATOLOGY, 2003, 39 : S139 - S142
[5] Synthesis and antiviral activity of oxaselenolane nucleosides
Chu, CK
Ma, L
Olgen, S
Pierra, C
Du, JF
Gumina, G
Gullen, E
Cheng, YC
Schinazi, RF
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (21) : 3906 - 3912
[6] Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks
Cullen, JM
Ll, DH
Brown, C
Eisenberg, EJ
Cundy, KC
Wolfe, J
Toole, J
Gibbs, C
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) : 2740 - 2745
[7] Daniel G., 2013, CLIN SCI, V124, P77
[8] A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION
DIENSTAG, JL
PERRILLO, RP
SCHIFF, ER
BARTHOLOMEW, M
VICARY, C
RUBIN, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) : 1657 - 1661
[9] Early kinetics of innate and adaptive immune responses during hepatitis B virus infection
Fisicaro, P.
Valdatta, C.
Boni, C.
Massari, M.
Mori, C.
Zerbini, A.
Orlandini, A.
Sacchelli, L.
Missale, G.
Ferrari, C.
[J]. GUT, 2009, 58 (07) : 974 - 982
[10] Gregory Y., 1999, ANTIMICROB AGENTS CH, V43, P190

← 1 2 3 →